Several AS protocols have emerged whose inclusion criteria are in accordance with the Epstein criteria [34]: a clinical stage of T1c, a PSA density <0.15 ng/mL, no Gleason pattern 4 or 5, <3 positive cores, and <50% cancer per core. Here, KLK3 is linked to cancer.